US Opposes Firm Shields Before Bayer Roundup Case

A substantial majority of Americans express concerns about pesticide use and reject shielding corporations from litigation regarding dangerous products, reveals a Reuters/Ipsos poll published ahead of Bayer’s (BAYGn.DE) crucial Supreme Court hearing scheduled for Monday ¹.

These polling findings underscore the political challenges facing the Trump administration, which has aligned itself with Bayer’s efforts to restrict Roundup litigation that threatens to impose billions in additional damages on the German pharmaceutical conglomerate.

Key Takeaways

78% of Americans concerned about pesticides in food crops
63% oppose protecting companies from cancer-causing product lawsuits
Supreme Court case could reshape pesticide litigation nationwide

Widespread Public Resistance to Corporate Protections

The Reuters/Ipsos examination of 4,557 U.S. adults revealed cross-party anxiety regarding pesticide safety, with 78% voicing concerns about pesticide application in food production ¹. Political affiliation showed minimal variance: Democrats at 81%, Republicans at 78%, and independents at 77%.

More significantly, 63% of survey participants rejected protecting corporations from legal action when marketing potentially cancer-causing products, regardless of warning labels. This sentiment included 71% of Democrats, 57% of Republicans, and 61% of independents ¹.

Supreme Court Case Implications

Bayer confronts roughly 181,000 Roundup-related claims and has allocated $16 billion for potential settlements ¹. The pharmaceutical giant is challenging a Missouri jury decision granting $1.25 million to John Durnell, who developed non-Hodgkin lymphoma following Roundup usage in a community garden.

The fundamental legal issue centers on whether federal pesticide authorizations supersede state failure-to-warn litigation. Bayer contends that EPA approval of Roundup’s labeling without cancer warnings creates federal protection against additional state mandates.

Electoral Consequences for Trump

The survey results indicate potential Republican weaknesses in upcoming November midterm contests. Trump’s endorsement of Bayer has frustrated certain Make America Healthy Again (MAHA) constituents who prioritize pesticide issues.

“Trump has a full understanding of how important the MAHA vote is to midterms,” said Kelly Ryerson, co-executive director of advocacy group American Regeneration, who attended White House meetings on the issue ¹.

Corporate Defense and Legal Opposition

Bayer threatens to remove glyphosate from American agricultural markets if litigation persists. “This is a bigger threat to innovation in general, when we think about agriculture,” said Jess Christiansen, head of communications for Bayer’s crop science division ¹.

Nevertheless, attorney Jim Onder, who represents over 20,000 Roundup plaintiffs, characterized Bayer’s Supreme Court appeal as “really grasping at straws.” He contended the corporation fears warning labels would harm sales ¹.

Comprehensive Health Anxieties

The survey demonstrated that 79% of Americans harbor concerns about health effects from chemicals, food additives, and microplastics in water supplies ¹. These results complement the MAHA movement’s expanded platform beyond pesticides, encompassing food colorants and synthetic additives.

The World Health Organization has classified glyphosate as “probably carcinogenic to humans,” though the EPA maintains it poses no cancer risk at approved usage levels ¹.

Political and Market Developments

Multiple states are evaluating legislation to protect pesticide manufacturers from failure-to-warn litigation. Georgia recently enacted such legislation, though Governor Brian Kemp has not revealed his signing intentions ¹.

Bayer has discontinued glyphosate use in U.S. residential lawn care products while maintaining agricultural distribution. The company’s shares continue experiencing pressure from ongoing legal expenses and regulatory uncertainty.

Not investment advice. For informational purposes only.